Eli Lilly and Almirall’s Ebglyss (lebrikizumab) has been shown to significantly improve the signs and symptoms of atopic ...

Adolescents with atopic dermatitis were also more likely than those without atopic dermatitis to experience bullying at a higher frequency (adjusted odds ratio, 1.97; 95% CI, 1.44–2.68) after ...

Eichenfield LF, Shi VY, Yu J, et al. Patient-reported impact of atopic dermatitis on pediatric and adolescent patients with moderate-to-severe disease: results of a real-world, cross-sectional survey.

Patients with atopic dermatitis experienced improvements in severity with 16 weeks of tralokinumab despite the number of ...

Key takeaways: The phase 3 ECZTRA 6 trial evaluated tralokinumab in adolescent atopic dermatitis. One-third of patients reached IGA score of 0 or 1 while more than half reached EASI 75 at 52 weeks.

Medical Journeys > Atopic Dermatitis For Your Patients: Atopic Dermatitis 101 — Here's what you need to know about this common skin disease. by Kristin Jenkins, Contributing Writer, MedPage Today ...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the international CorEvitas Adolescent Atopic Dermatitis (AD ...

Dupilumab was shown to be well-tolerated and effective in treating pediatric and adolescent atopic dermatitis (AD) regardless of age, sex, or ethnicity in a study recently published in The Journal ...

Thermo Fisher Scientific TMO announced the launch of the international CorEvitas Adolescent Atopic Dermatitis (AD) Registry, designed to study novel treatments for the most common inflammatory ...

Dupixent ® (dupilumab) Phase 3 data show significant improvement in severe atopic dermatitis for children aged 6 to 11 years Detailed data to be presented at the Revolutionizing Atopic Dermatitis ...

And atopic dermatitis is a specific form of and the most common type of eczema," dermatologist Naana Boakye, MD, says. It's a widespread condition, affecting one in 10 people, ...

Atopic dermatitis (eczema) is a long-lasting skin condition that can make areas of your skin extremely itchy. It also causes rashes that make your skin dry, inflamed, bumpy, scaly, or crusty.